FDA Import Refusal AEK-2087812-9/50003/1 — LABORATE PHARMACEUTICALS INDIA L
The FDA refused shipment AEK-2087812-9/50003/1 from LABORATE PHARMACEUTICALS INDIA L (India) on Sep 30, 2026. The refused product falls under Drugs and Biologics — DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- Sep 30, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62GDA90 DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY)
- Charges
- 75